IQ Healthy Hearts ETF
HART
HART was delisted on the 19th of August, 2025.
2 hedge funds and large institutions have $5.24M invested in IQ Healthy Hearts ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
6.4% less ownership
Funds ownership: 86.16% → 79.76% (-6.4%)
15% less capital invested
Capital invested by funds: $6.13M → $5.24M (-$895K)
60% less funds holding
Funds holding: 5 → 2 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MSL
Mackay Shields LLC
New York
|
-$5.67M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$223K |
| 3 |
Jane Street
New York
|
-$220K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12K |
HART Hedge Fund Activity: Q2 2022 in Review
2 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in IQ Healthy Hearts ETF (HART) for Q2 2022, worth a combined $5.24M — down 15% from $6.13M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of HART and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Mackay Shields LLC, exiting entirely with an estimated $5.67M sold.
- 2 institutional investors held IQ Healthy Hearts ETF (HART) as of Q2 2022, down from 5 in Q1 2022.
- Funds reported $5.24M of IQ Healthy Hearts ETF stock for Q2 2022, down 15% quarter-over-quarter.
- 1 fund opened new IQ Healthy Hearts ETF positions in Q2 2022 and 4 closed out, a net change of -3 holders.
- The largest IQ Healthy Hearts ETF seller in Q2 2022 was Mackay Shields LLC, an estimated $5.67M sold.
Based on aggregated 13F filings for Q2 2022.